Is the FDA Stepping Into the 21st Century?

Posted by Ed Schoonveld on Wed, Mar 22, 2017

Until recently, the pharmaceutical industry has been severely limited in its ability to communicate with customers regarding the economic impact of new drug treatments. Under the 21st Century Cures Act, which was approved with broad bipartisan support and signed by then-President Barack Obama in December 2016, the pharmaceutical industry has a much broader mandate to discuss healthcare economic information with payers and formulary decision makerswith some fairly reasonable requirements.

Read More